Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors

Cancer

Volumn 94, Issue 1, 2002, Pages 141-151

  Tokumura, Akira ^a   Tominaga, Kyoko ^a   Yasuda, Katsuhiko ^b   Kanzaki, Hideharu ^b   Kogure, Kentaro ^a   Fukuzawa, Kenji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Human serum; Lysophosphatidic acid; Lysophosphatidylcholine; Lysophospholipase D; Ovarian carcinoma; Polyunsaturated fatty acid

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; HUMANS; LYSOPHOSPHOLIPIDS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PHOSPHORIC DIESTER HYDROLASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0036140653     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10146     Document Type: Article

References (39)

1. A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization and mechanism of action
2. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours
3. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
4. Lysophospholipids activate ovarian and breast cancer cells
5. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
6. Malignant effusions contain lysophosphatidic acid (LPA)-like activity
7. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
8. A family of phospholipid autacoids: Occurrence, metabolism and bioactions
9. Pharmacologically active acidic phospholipids and glycolipids
10. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species
11. Lysophosphatidate-induced cell proliferation
12. Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator
13. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
14. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
15. Molecular cloning of the human Edg2 protein and its identification as functional cellular receptor for lysophosphatidic acid
16. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG-7, for lysophosphatidic acid
17. Molecular cloning of a high-affinity receptor for the growrh factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes
18. Lysophosphatidic acid as a phospholipid mediator: Pathways of synthesis
19. Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma
20. Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma
21. Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats
22. A rapid method of total lipid extraction and purification
23. Sialyl-Tn, sialyl-Lewis Xi, CA19-9, CA125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors
24. Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6)
25. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2II6 α-N-acetylgalactosaminyl (sialosyl-Tn)
26. Dissociation in serum CA125 concentrations measured by different monoclonal antibodies
27. Production of lysophosphaddic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients
28. Stimulatory effect of lysophosphatidic acid on uterine smooth muscles of non-pregnant rats
29. Contractile actions of lysophosphatidic acids with a chemically-defined fatty acyl group on longitudinal muscle from guinea-pig ileum
30. Lysophosphatidic acids induce contraction of rat isolated colon by two different mechanisms
31. Studies of lysophospholipase D of rat liver and other tissues
32. Metabolism of platelet-activating factor in rat epididymal spermatozos
33. The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla
34. Phorbol 12-myristate 13 acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells
35. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients
36. The biochemical modification of the erythrocyte membranes from women with ovarian cancer
37. 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers
38. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis
39. Abnormal serum lysophospholipids in multiple myeloma patients